Alternate Names : Coagulopathy
Definition
Bleeding disorders are a group of conditions in which there is a problem with the body’s blood clotting process. These disorders can lead to heavy and prolonged bleeding after an injury. Bleeding can also begin on its own.
See also:
- Acquired platelet function defects
- Congenital platelet function defects
- Congenital antithrombin III deficiency
- Congenital protein C or S deficiency
- Disseminated intravascular coagulation (DIC)
- Drug-induced immune thrombocytopenia
- Factor II deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XII deficiency
- Hemophilia A
- Hemophilia B
- Idiopathic thrombocytopenic purpura (ITP)
- Von Willebrand’s disease (type I and type II)
Overview, Causes, & Risk Factors
Normal blood clotting involves as many as 20 different plasma proteins, which are known as blood clotting or coagulation factors. These factors act together with other chemicals to form a substance called fibrin that stops bleeding.
Problems can occur when certain coagulation factors are low or missing. Bleeding problems can range from mild to severe.
Some bleeding disorders are present at birth and are passed through families (inherited). Others develop from:
- Illnesses such as vitamin K deficiency or severe liver disease
- Treatments such as the use of drugs to stop blood clots (anticoagulants) or the long-term use of antibiotics
Bleeding disorders can also result from having poorly working or too few of the blood cells that promote blood clotting (platelets). These disorders can also be either inherited or picked up (acquired). The side effects of certain drugs often lead to the acquired forms.
-
Bleeding disorders : Overview, Causes, & Risk Factors
-
Bleeding disorders : Symptoms & Signs, Diagnosis & Tests
-
Bleeding disorders : Treatment
Review Date : 3/2/2009
Reviewed By : David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
